Summary of The Antidote
A Small Competitor Challenges the Drug Giants
From THE ANTIDOTE by Barry Werth. Copyright © by Barry Werth. Reprinted by permission of Simon & Schuster Inc.
Vertex Pharmaceuticals aims to change the world of Big Pharma.
Even if you regularly take a prescription drug, you might not consider the money, time, research and effort that went into creating and marketing your daily pill. But rest assured, somebody worked quite hard to create it. Journalist Barry Werth’s second study of the plucky start-up Vertex Pharmaceuticals follows Vertex founder Joshua Boger and his team in their quest to develop groundbreaking drugs for hepatitis C and cystic fibrosis. The saga has a happy outcome, but Vertex bled billions of dollars along the way. Werth could have cut his page count by a quarter or a third and not lost the essence of his tale. And when Boger steps down as CEO – when the hero of the story leaves the stage – the drama suffers. Still, Werth presents gripping insights into the pharmaceutical industry and the tortuous path pioneering drugs take to get to market. getAbstract recommends this eye-opening saga to investors, entrepreneurs, start-ups, students of finance and anyone fascinated by the complexities of the high-stakes pharmaceutical market.
In this summary, you will learn
- How Joshua Boger made Vertex Pharmaceuticals into a major drug company
- How Vertex developed new drugs to treat hepatitis C and cystic fibrosis
Comment on this summary
Customers who read this summary also read
Adam von Gootkin
Career Press, 2015
Ouray Mills, 2016
Ed McLaughlin et al.
Greenleaf Book Group, 2016
Paul B. Brown